Apricus Biosciences, Inc. (APRI)
|
3.34
0.00 (0.00%)
|
|
|
|
APRI additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
APRI Profile
•
Exchange
NASDAQ
•
Sector
Not Available
•
Industry
Not Available
•
Held by these Mutual Funds
Not Available
•
Executives
Dr. Bassam B. Damaj Ph.D.
Chairman
Chief Exec. officer Pres and Member of Fin. Committee
Mr. Steve Martin
Chief Financial Officer
Sr. VP and Treasurer
Mr. Randy J. Berholtz Esq. r>Exec. VP
Gen. Counsel and Sec.
Mr. Edward M. Cox
VP of Corp. Devel. & Investor Relations
Dr. Richard Martin Ph.D.
VP of Chemistry - NexMed (U.S.A.) Inc.
Chairman
Chief Exec. officer Pres and Member of Fin. Committee
Mr. Steve Martin
Chief Financial Officer
Sr. VP and Treasurer
Mr. Randy J. Berholtz Esq. r>Exec. VP
Gen. Counsel and Sec.
Mr. Edward M. Cox
VP of Corp. Devel. & Investor Relations
Dr. Richard Martin Ph.D.
VP of Chemistry - NexMed (U.S.A.) Inc.
•
Employee Count
25
Special Offers
Competitors
APRI earnings
Date
Actual
Expected
Prev Yr Qtr
7/1/2008
-0.09
-0.08
